幽门螺杆菌对诺氟沙星及其他药物的敏感性比较。
Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents.
作者信息
Shungu D L, Nalin D R, Gilman R H, Gadebusch H H, Cerami A T, Gill C, Weissberger B
出版信息
Antimicrob Agents Chemother. 1987 Jun;31(6):949-50. doi: 10.1128/AAC.31.6.949.
Abstract
Twenty-one strains of Campylobacter pylori (Campylobacter pyloridis) were tested for susceptibility to norfloxacin and other agents by the serial agar dilution method. Ampicillin (MIC for 90% of isolates [MIC90], 0.016 micrograms/ml) and famotidine (MIC90, greater than 1,024 micrograms/ml) were, respectively, the most and the least active of the agents tested. Norfloxacin (MIC90, 1 microgram/ml) and imipenem (MIC90, 0.125 micrograms/ml) were substantially active against this organism.
摘要
采用连续琼脂稀释法对21株幽门弯曲菌（幽门螺杆菌）进行了诺氟沙星和其他药物的敏感性测试。氨苄西林（90%分离株的最低抑菌浓度[MIC90]为0.016微克/毫升）和法莫替丁（MIC90大于1024微克/毫升）分别是受试药物中活性最高和最低的。诺氟沙星（MIC90为1微克/毫升）和亚胺培南（MIC90为0.125微克/毫升）对该菌具有显著活性。
相似文献
1
Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents.幽门螺杆菌对诺氟沙星及其他药物的敏感性比较。
Antimicrob Agents Chemother. 1987 Jun;31(6):949-50. doi: 10.1128/AAC.31.6.949.
2
Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents.幽门螺杆菌临床分离株对24种抗菌和抗溃疡药物的敏感性。
Eur J Epidemiol. 1988 Jun;4(2):154-7. doi: 10.1007/BF00144743.
3
The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.抗生素和抗溃疡药物对幽门弯曲菌的最低抑菌浓度和杀菌浓度。
J Antimicrob Chemother. 1986 Mar;17(3):309-14. doi: 10.1093/jac/17.3.309.
4
Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.六种新型氟喹诺酮类药物及其他口服抗菌药物对幽门螺杆菌的体外比较活性
Antimicrob Agents Chemother. 1989 Jan;33(1):108-9. doi: 10.1128/AAC.33.1.108.
5
In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics.幽门弯曲菌对西咪替丁、硫糖铝、铋及十六种抗生素的体外敏感性
Acta Pathol Microbiol Immunol Scand B. 1987 Apr;95(2):147-9. doi: 10.1111/j.1699-0463.1987.tb03103.x.
6
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.幽门弯曲菌临床分离株对11种抗菌药物的敏感性
Antimicrob Agents Chemother. 1985 Dec;28(6):837-8. doi: 10.1128/AAC.28.6.837.
7
In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori).枸橼酸铋与多种抗菌剂对幽门弯曲菌（幽门螺杆菌）的体外协同活性。
Antimicrob Agents Chemother. 1987 Sep;31(9):1429-30. doi: 10.1128/AAC.31.9.1429.
8
The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics.
J Clin Gastroenterol. 1990;12 Suppl 1:S135-8. doi: 10.1097/00004836-199001001-00023.
9
引用本文的文献
1
A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.用于根除幽门螺杆菌感染的药物的风险效益评估。
Drug Saf. 1996 Jul;15(1):30-52. doi: 10.2165/00002018-199615010-00003.
2
Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.pH值变化对幽门螺杆菌对三种大环内酯类抗菌药物及替马沙星敏感性的影响
Eur J Clin Microbiol Infect Dis. 1993 Feb;12(2):131-3. doi: 10.1007/BF01967591.
3
Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.兰索拉唑单独及与抗菌药物联合对幽门螺杆菌的抗菌特性。
Eur J Clin Microbiol Infect Dis. 1995 May;14(5):391-9. doi: 10.1007/BF02114894.
4
Mechanisms of antibiotic resistance in Campylobacter species.弯曲杆菌属细菌的抗生素耐药机制。
Antimicrob Agents Chemother. 1988 Aug;32(8):1107-12. doi: 10.1128/AAC.32.8.1107.
5
Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.氟喹诺酮类抗生素。微生物学、药代动力学及临床应用。
Drugs. 1988 Aug;36(2):193-228. doi: 10.2165/00003495-198836020-00004.
6
Treatment failure of norfloxacin against Campylobacter pylori and chronic gastritis in patients with nonulcerative dyspepsia.诺氟沙星治疗非溃疡性消化不良患者幽门螺杆菌感染及慢性胃炎的失败情况。
Antimicrob Agents Chemother. 1989 Feb;33(2):256-7. doi: 10.1128/AAC.33.2.256.
7
Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.六种新型氟喹诺酮类药物及其他口服抗菌药物对幽门螺杆菌的体外比较活性
Antimicrob Agents Chemother. 1989 Jan;33(1):108-9. doi: 10.1128/AAC.33.1.108.
8
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
9
Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents.不同pH值对幽门螺杆菌对抗菌药物敏感性的影响。
Eur J Clin Microbiol Infect Dis. 1989 Oct;8(10):888-9. doi: 10.1007/BF01963775.
10
Campylobacter pylori and gastroduodenal disease.幽门螺杆菌与胃十二指肠疾病
Clin Microbiol Rev. 1990 Jan;3(1):1-12. doi: 10.1128/CMR.3.1.1.
本文引用的文献
1
Antibiotic sensitivity of "Campylobacter pylori".
Eur J Clin Microbiol. 1984 Oct;3(5):444. doi: 10.1007/BF02017370.
2
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.胃炎和消化性溃疡患者胃内不明弯曲杆菌。
Lancet. 1984 Jun 16;1(8390):1311-5. doi: 10.1016/s0140-6736(84)91816-6.
3
Characterization of "Campylobacter pyloridis" by culture, enzymatic profile, and protein content.通过培养、酶谱和蛋白质含量对“幽门弯曲菌”进行鉴定。
J Clin Microbiol. 1985 Dec;22(6):1007-10. doi: 10.1128/jcm.22.6.1007-1010.1985.
4
Pyloric Campylobacter infection and gastroduodenal disease.幽门弯曲杆菌感染与胃十二指肠疾病
Med J Aust. 1985 Apr 15;142(8):439-44. doi: 10.5694/j.1326-5377.1985.tb113444.x.
5
Relation of Campylobacter pyloridis to gastritis and peptic ulcer.幽门弯曲菌与胃炎及消化性溃疡的关系。
J Infect Dis. 1986 Apr;153(4):664-9. doi: 10.1093/infdis/153.4.664.
6
Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.诺氟沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1985 Dec;30(6):482-513. doi: 10.2165/00003495-198530060-00003.
7
The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.抗生素和抗溃疡药物对幽门弯曲菌的最低抑菌浓度和杀菌浓度。
J Antimicrob Chemother. 1986 Mar;17(3):309-14. doi: 10.1093/jac/17.3.309.
8
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.幽门弯曲菌临床分离株对11种抗菌药物的敏感性
Antimicrob Agents Chemother. 1985 Dec;28(6):837-8. doi: 10.1128/AAC.28.6.837.
9
Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.法莫替丁。药效学和药代动力学特性及其在消化性溃疡疾病和佐林格-埃利森综合征治疗应用的初步综述。
Drugs. 1986 Sep;32(3):197-221. doi: 10.2165/00003495-198632030-00001.
10
Urea hydrolysis in patients with Campylobacter pyloridis infection.
Lancet. 1986 Apr 26;1(8487):965-6. doi: 10.1016/s0140-6736(86)91060-3.
Zotero 插件